Evidence map›Paper›PMID 40107744›Full record

ArticleBMJ case reports2025

Accidental protonitazene intoxication: clinical management and detection of a novel opioid.

Jonathan Meltzer, Alexandra Boucher, Sabine Cohen, Julia Morere

Abstract readCase Reports
In one paragraph

Article in BMJ case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jonathan MeltzerAnesthesiology and Critical Care, Centre Hospitalier Lyon-Sud, Pierre-Benite, France cyrus4@gmx.com.ORCID http://orcid.org/0009-0009-3497-5969
Alexandra BoucherToxicology Lab, Centre Hospitalier Lyon-Sud, Pierre-Benite, France.
Sabine CohenToxicology Lab, Centre Hospitalier Lyon-Sud, Pierre-Benite, France.
Julia MorereEmergency Medicine, Hôpital Edouard Herriot, Lyon, Rhône-Alpes, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We describe the management by a pre-hospital medical team of a typical opioid toxidrome in a young man after consumption of an unknown substance with complete reversion after injection of unusually high doses of naloxone.The initial toxicological screening was negative. The secondary identification of protonitazene was performed several months after the first intoxication, both in the substance consumed and in the patient's blood samples. Protonitazene is a morphine derivative representing an emerging drug whose consumption is underestimated, escaping conventional toxicological screening and detected for the first time in France.The implementation of rapid detection procedures by the Lyon toxicology laboratory and the testing of these procedures during a second intoxication of the same patient allowed for the diagnosis to be reached again in record time.

Indexed as

Analgesics, OpioidMorphineNaloxoneAdultBenzamidesHumansMaleNarcotic AntagonistsAnalgesics, OpioidBenzamidesMorphineNaloxoneNarcotic AntagonistsU-47700Adult intensive careMedical managementPoisoningPrehospitalToxicology

Identifiers

PMID40107744
PMCPMC11926966

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.